Fidelity Investments’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$449M Sell
7,799,653
-423,035
-5% -$24.4M 0.03% 525
2025
Q1
$479M Buy
8,222,688
+63,480
+0.8% +$3.7M 0.03% 469
2024
Q4
$657M Buy
8,159,208
+866,328
+12% +$69.8M 0.04% 376
2024
Q3
$584M Buy
7,292,880
+3,070
+0% +$246K 0.04% 423
2024
Q2
$445M Sell
7,289,810
-234,067
-3% -$14.3M 0.03% 488
2024
Q1
$372M Buy
7,523,877
+162,033
+2% +$8.01M 0.03% 553
2023
Q4
$309M Sell
7,361,844
-191,616
-3% -$8.03M 0.02% 583
2023
Q3
$248M Buy
7,553,460
+870,364
+13% +$28.6M 0.02% 617
2023
Q2
$236M Sell
6,683,096
-46,777
-0.7% -$1.65M 0.02% 661
2023
Q1
$191M Buy
6,729,873
+181,948
+3% +$5.17M 0.02% 722
2022
Q4
$272M Buy
6,547,925
+91,609
+1% +$3.81M 0.03% 584
2022
Q3
$268M Buy
6,456,316
+471,345
+8% +$19.5M 0.03% 566
2022
Q2
$196M Buy
5,984,971
+1,032,091
+21% +$33.7M 0.02% 696
2022
Q1
$173M Buy
4,952,880
+1,078,877
+28% +$37.7M 0.01% 846
2021
Q4
$93.6M Buy
3,874,003
+502,838
+15% +$12.2M 0.01% 1125
2021
Q3
$119M Buy
+3,371,165
New +$119M 0.01% 1024